Department of Molecular and Cellular Biochemistry, Markey Cancer Center, University of Kentucky, Lexington, KY 40506, USA.
J Mol Cell Biol. 2010 Apr;2(2):70-3. doi: 10.1093/jmcb/mjp040. Epub 2009 Dec 11.
A new study in Nature has identified a small molecule inhibitor for the oncogenic Wnt/beta-catenin pathway that is responsible for many human cancers. This inhibitor targets an unsuspected cellular enzyme, Tankyrase, which controls the destruction of a beta-catenin destructor.
一项发表在《自然》杂志上的新研究鉴定出一种小分子抑制剂,该抑制剂针对致癌性的 Wnt/β-连环蛋白信号通路,而该通路与许多人类癌症的发生有关。这种抑制剂的作用靶点是一种此前不为人知的细胞内酶——端锚聚合酶(Tankyrase),它可以控制β-连环蛋白降解酶的破坏。